Status new methods

CIPAC Methods, when proposed by a company or an organization get a first status (draft method) when they are discussed in a CIPAC Meeting. After having been accepted, they receive the status "provisional" in a following CIPAC Meeting, and finally they are accepted as full methods.

In addition, methods may be revised, especially in case of CIPAC MT's. Release of revised methods follow the same procedure by CIPAC.

 

DAPF document: Summary of New & Revised CIPAC MT methods

The purpose of the doucment was created and is maintained by DAPF to provide an overview of actual and older/superseded versions of MT methods. 
This document is published on the CIPAC website as CIPAC sees the benefit to support registration applicants, authorities and regulatory bodies as well as control labs on the status of the most recent methods and versions. CIPAC is encouraging the use of the actual methods & versions. However, the German DAPF has created it and is fully responsible for its content and any amendment.
Further information about the German DAPF you find here. 

Decisions of the 66th CIPAC virtual meeting June 2022

The table "Decisions of the 66th CIPAC Meeting" presented below the methods which are either accepted as provisional or full methods. 

 
CIPAC no. /
 name


Description

Status

 Published

1006 28-homobrassinolide

The reversed phase HPLC method (CIPAC/5269) for the determination of 28-homobrassinolide in TC, SL and EC formulations was accepted as a full CIPAC method.


full

pre-published
 method
133 ametryn
The capillary GC method using internal standard (CIPAC/5265) for the determination of ametryn in TC, WG and SC formulations was accepted as a full CIPAC method.

full

pre-published
 method

221 chlorpyrifos

The reversed phase HPLC method (CIPAC/5277) for the determination of chlorpyrifos in TC and EC formulations was accepted as a full CIPAC method.


full

pre-published
 method

494 tebuconazole

The extension of the scope (CIPAC/5287) of CIPAC method 494/WP/M/3 for the determination of the tebuconazole content in EC formulations was accepted as a full CIPAC method.


full

pre-published
 method

xxx 14-hydroxylated brassinosteroid

The reversed phase HPLC method (CIPAC/5311) for the determination of 14-hydroxylated brassinosteroid in TK and SL formulations was accepted as provisional CIPAC method with additional justification for the Horrat >1 and for the eliminations.


provisional

no


 687
difenoconazole

The capillary gas chromatographic method with split injection, using 1,3,5-triphenylbenzene as internal standard (CIPAC/5324), for the determination of difenoconazole in TC, EC and WG formulations was accepted as provisional CIPAC method considering the data sets using hydrogen or helium as eluent gas with the need for a stricter description of the method.


provisional

no

373 ethephon

The ion-chromatographic  method (CIPAC/5315) for the determination of ethephon in TC, TK and SL formulations was accepted as provisional CIPAC method, without the need to eliminate outliers in the case of TC samples.


provisional

no

578 flumioxazin

The extension of the reversed phase HPLC method 578 (CIPAC/5330) to the determination of flumioxazin in SC and WG formulations was accepted as provisional CIPAC method.ifenoconazole


provisional

no

xxx matrine

The reversed phase HPLC method (CIPAC/5313) for the determination of matrine in TK and SL formulations was accepted as provisional CIPAC method.


provisional

no

414 methoprene

The extension of the reversed phase HPLC method 414 (CIPAC/5305) to the determination of methoprene in GR, GR-SB and CS formulations was accepted as provisional CIPAC method.


provisional

no

239 pirimiphos-methyl

The extension of the gas chromatographic method 239 (CIPAC/5301) to the determination of pirimiphos-methyl in LN formulations was accepted as provisional CIPAC method.


provisional

no

183 trifluralin

The reversed phase HPLC method (CIPAC/5303) for the determination of trifluralin in TC and EC formulations was accepted as provisional CIPAC method.


provisional

no

333 + 570 deltamethrin + chlorfenapyr

The reversed phase HPLC method (CIPAC/5297) for the determination of deltamethrin in TC, chlorfenapyr in TC and deltamethrin + chlorfenapyr in LN formulations was accepted as provisional CIPAC method with the need to modify the description of the method considering the column and specifying the resolution.


provisional

no

MT 178.3 attrition resistance

The revision of methods MT 178 and MT 178.2  (CIPAC/5321) to combine into a single method for granular products and to include loosely packed tablets was accepted as provisional CIPAC method with the editorial changes and with the remark that MT 178.3 supersedes MT 178 and MT 178.2.


provisional

no

MT XXX Discharge rate of trigger dispenser

The method for determination of the discharge rate of trigger dispensers (CIPAC/5152) was accepted as provisional CIPAC method with  the need for further clarifications from DAPF considering packaging types.


provisional

no

MT XXX Discharge rate of aerosol dispenser
 
The method for determination of the discharge rate of aerosol dispenser (CIPAC/5153) was accepted as provisional CIPAC method.


provisional

no

MT 160.1 Spontaneity of despersion of suspension concentrates

The revision of methods MT 160 (CIPAC/5323) to determine the spontaneity of dispersion of liquid formulations forming suspensions on dilution with water was accepted as provisional CIPAC method with the remark that MT 160.1 supersedes MT 160.


provisional

no